StratDeck

Two stocks in Healthcare

Eli Lilly and Company vs Medtronic: profit, growth, debt and price compared

Eli Lilly and Company and Medtronic are each stronger on 3 of 7 figures: Eli Lilly and Company on profit margin, sales growth and price trend; Medtronic on debt, price for its expected profit and dividend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Eli Lilly and Company's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Eli Lilly and Company and Medtronic side by side
Eli Lilly and CompanyLLYMedtronicMDT
Net marginStronger: 31.9%13.9%
Revenue growth, past yearStronger: +38.61%+13.73%
Debt to equity122.9%Stronger: 55.4%
Forward P/E27.2×Stronger: 15.7×
Dividend yield0.49%Stronger: 2.83%
AnalystsBuy · 29Buy · 26
From its 200-day averageStronger: +21.2%+12.5%

Share price over the past year

  • Eli Lilly and Company+34.2%
  • Medtronic−0.1%

18 Nov 202518 Nov 2026

Eli Lilly and Company or Medtronic: which is stronger?

  • LLY

    Which is more profitable?

    Eli Lilly and Company keeps more of each sale as profit: 31.9% against 13.9%.

  • LLY

    Which is growing its sales faster?

    Eli Lilly and Company is growing its sales faster: +38.61% over the past year, against +13.73%.

  • MDT

    Which has borrowed less?

    Medtronic has borrowed less: its debt is 55.4% of what its shareholders own, against 122.9% for Eli Lilly and Company.

  • MDT

    Which costs less for the profit it is expected to make?

    Medtronic costs less for the profit it is expected to make: 15.7× its forward earnings, against 27.2×.

  • MDT

    Which pays more in dividends?

    Medtronic pays more back in dividends for what a share costs: 2.83% a year, against 0.49%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • LLY

    Which is in the stronger price trend?

    Eli Lilly and Company's price is in the stronger trend: 21.2% above its 200-day average, against 12.5% above.

What each company does

LLYEli Lilly and Company

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Reports results on 3 February 2027

MDTMedtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.

Reports results on 24 November 2026

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.